Skip to main content
. 2014 Mar 8;105(4):437–444. doi: 10.1111/cas.12361

Fig. 2.

Fig. 2

Survival analyses of the patients among germinal center B cell phenotype (GCB) and non-GCB groups. (a,b) Overall survival (a) and progression-free survival (b) of each group. (c,d) Overall survival (c) and progression-free survival (d) according to BACH2 expression levels.